ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell … – GlobeNewswire (press release)

Continue reading

2018-03-05 Michael Zand NEWS

Cancer stem cells, allies of the tumor and enemies of the patient – EurekAlert (press release)

EurekAlert (press release)Cancer stem cells, allies of the tumor and enemies of the patientEurekAlert (press release)They want to uncover the physiological mechanisms of the cancer stem cell, the arch-enemy of the patient because it is responsible for … Continue reading

2018-03-05 Michael Zand NEWS

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial – GlobeNewswire (press release)


GlobeNewswire (press release)

Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell …
GlobeNewswire (press release)
Dr. Doug Schmid, Chief Science and Lab Officer, at Predictive Biotech, Inc. presented his topic during the March 1-2, 2018 4th Annual Perinatal Stem Cell Society Congress, Salt Lake City, UT, titled: “Wharton’s Jelly: A Perinatal Cytokine Reservoir …

Continue reading

2018-03-05 Michael Zand NEWS

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial – Nasdaq

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
GlobeNewswire (press release)
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth …

Continue reading

2018-03-05 Michael Zand NEWS

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial – Nasdaq

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
Nasdaq
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth …

and more »

Continue reading

2018-03-05 Michael Zand NEWS

Synthetic Biology Tools Market will experience a noticeable growth during the forecast period 2018 – 2026 – Investor Opinion

Synthetic Biology Tools Market will experience a noticeable growth during the forecast period 2018 – 2026Investor Opinion“Synthetic Biology Tools Market: Global Industry Trends, Market Size, Competitive Analysis and Forecast – 2018 – 2026”, this study … Continue reading

2018-03-05 Michael Zand NEWS

Targeted evolution: Why are we so afraid of CRISPR gene editing? – Genetic Literacy Project

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
Nasdaq
CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth …

and more »

Continue reading

2018-03-05 Michael Zand NEWS

Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic … – GlobeNewswire (press release)

Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic …GlobeNewswire (press release)SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), cellular th… Continue reading

2018-03-05 Michael Zand NEWS
  • 1
  • …
  • 446
  • 447
  • 448
  • 449
  • 450
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Literacy Project

Targeted evolution: Why are we so afraid of CRISPR gene editing?
Genetic Literacy Project
The potential applications of CRISPR are enormous. It’s the closest we’ve ever come to a cure for cancer. We’ve already been able to cure HIV infection in animal models, and even in human cell cultures, by removing the viral genes that insert …